Esomeprazole Magnesium Capsule, Coated Pellets
Product Images NDC 71205-706

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 71205-706). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71205-706-30 (Esomeprazole 20mg 30cap)

Label for Esomeprazole Magnesium 20 mg delayed-release capsules by Proficient Rx LP, with NDC 71205-706-30. The label lists capsule contents, including Esomeprazole Magnesium Trihydrate USP equivalent to 20 mg esomeprazole, describes capsule appearance, and provides manufacturing details by Alkem Laboratories in India. It also notes storage conditions and warnings.*

FDA Label Image

Esomeprazole-fig2 (Esomeprazole Fig2)

A line graph depicting the percentage maintained over a 6-month period for four groups: Esomeprazole 40 mg, Esomeprazole 20 mg, Esomeprazole 10 mg, and Placebo. The x-axis represents months with scheduled visits, and the y-axis shows percent maintained, illustrating comparative trends among the groups over time.*

FDA Label Image

Esomeprazole-fig3 (Esomeprazole Fig3)

A line graph depicting the percentage of patients maintaining a condition over a six-month period for four groups: Esomeprazole 40 mg, 20 mg, 10 mg, and placebo. The y-axis shows percent maintained from 0 to 100%, and the x-axis represents months with scheduled visits noted. The 40 mg and 20 mg groups maintain near 100%, 10 mg shows a gradual decline, and placebo declines sharply to about 30%.*

FDA Label Image

Esomeprazole-fig4 (Esomeprazole Fig4)

A line graph showing the percent of patients symptom-free over 28 diary days for three groups: Esomeprazole 40 mg, Esomeprazole 20 mg, and placebo. The y-axis represents percent symptom-free patients, and the x-axis represents diary days from 0 to 28. Both Esomeprazole groups show higher symptom-free percentages than placebo over time.*

FDA Label Image

Esomeprazole-fig5 (Esomeprazole Fig5)

A line graph illustrating the percent of patients symptom-free over a 28-day period for Esomeprazole 40 mg, Esomeprazole 20 mg, and placebo groups. The x-axis represents diary days from 0 to 28, and the y-axis represents the percent of patients symptom-free from 0 to 100%. Esomeprazole 40 mg and 20 mg show higher symptom-free percentages compared to placebo throughout the study.*

FDA Label Image

Esomeprazole-structure (Esomeprazole Structure)

Chemical structure of esomeprazole magnesium, showing two esomeprazole molecules complexed with a magnesium ion and three water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.